Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia

Autor: S Al Shamakhi, Ali AlMadhani, M. Al Rawahi, Anil Pathare, Said Y. ALKindi, Y. Wali, S Al-Ruqeishi, Salam Alkindi, Muhanna Almusalhi, B Al Rawahi, R A Elsadek, J Al-Yazeedi, G Al-Khadouri
Rok vydání: 2021
Předmět:
Male
0301 basic medicine
Abdominal pain
Reticulocytes
Comorbidity
Infectious and parasitic diseases
RC109-216
Gastroenterology
Cohort Studies
Leukocyte Count
0302 clinical medicine
Prospective Studies
030212 general & internal medicine
Prospective cohort study
biology
Vasooclusive crises
General Medicine
Hospitalization
Infectious Diseases
medicine.anatomical_structure
Cohort
Female
medicine.symptom
Cohort study
Adult
Microbiology (medical)
medicine.medical_specialty
030106 microbiology
Anemia
Sickle Cell

Article
03 medical and health sciences
Internal medicine
White blood cell
Acute Chest Syndrome
medicine
Humans
Lymphocyte Count
L-Lactate Dehydrogenase
Platelet Count
SARS-CoV-2
business.industry
Sickle cell anaemia
COVID-19
SCA
medicine.disease
Acute chest syndrome
Coronavirus
Ferritin
Ferritins
biology.protein
business
Zdroj: International Journal of Infectious Diseases, Vol 106, Iss, Pp 128-133 (2021)
International Journal of Infectious Diseases
ISSN: 1201-9712
Popis: Objectives The aim of this study was to assess the impact of COVID-19 on the morbidity and mortality on vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients. Methods One hundred patients with(fifty) or without COVID-19 PCR positivity(fifty), were enrolled in a prospective cohort study after signing a written informed consent. Results The COVID-19 positive patients had significantly higher median VOC episodes/year i.e 3 /year (IQR, 1-6 /year) v/s 2 /year (IQR, 2-12 /year) (p
Databáze: OpenAIRE